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The present work aims to investigate several parameters associated
to the metabolic reprogramming that occurs when cells progress from
the normal stage to malignant transformation and metastasis. We used
a murine model of melanoma in order to approach the matter. In this
model amelanocyte cell linewas subjected to several cycles of adhesion
impediment, resulting in stable cell lines exhibiting phenotypes
corresponding to different stages of malignization: non-tumorigenic
cells melan-a (original murine melanocytes); non-tumorigenic cell line
4C (obtained after 4 cycles of adherence abrogation); non-metastatic
4C11− andmetastatic 4C11+melanoma cell lines, obtained bydiluting
the cells from the spheroids of 4C cell line [1]. The metabolic proﬁle of
each of these different cell lines was investigated by evaluation of the
relevant parameters of glycolytic and oxidative metabolic pathways.
Our results showed that metastatic cell line (4C11+) released the
highest amounts of lactate and displayed increased pyruvate kinase
(PK) and lactate dehydrogenase (LDH) activities. These results are
compatible with the Warburg effect typical of tumor cells. In contrast,
results obtained with high-resolution respirometry with 4C11+ intact
cells indicated an increased oxidative metabolism, with increased rates
of oxygen consumption coupled to ATP synthesis when compared to
the other cellular stages. We believe this is a consequence of
mitochondrial biogenesis, leading to rescue of mitochondrial function,
a condition believed to be necessary to metastasis. We are currently
conducting studies to conﬁrm this hypothesis. We also observed an
increase in hexokinase activity bound to mitochondria (mt-HK) in the
non-tumorigenic 4C cells. When compared to normal cells (melan a),
no increased activity was observed in other glycolytic enzymes such as
LDH and PK, suggesting that the increase in the mt-HK activity is
unrelated to the modulation of glycolytic ﬂux. We believe this HK
activity is part of an antioxidant mechanism [2]. A detailed character-
ization of these effects in a model of tumor progression might reveal
new targets for the development of more speciﬁc therapies against
cancer and help the understanding of the metastatic process.
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Glycogen branching enzyme (GBE1) deﬁciency leads to a genetic
disease: glycogen storage disease type IV (GSD IV). The effect of this
deﬁciency is an accumulation of poorly branched glycogen molecules,
which have lower intracellular solubility and may lead to mechanical
cell damage. Another consequence is slower glucose release from
such glycogen, which can in turn disturb the energy metabolism.
The symptoms of GSD IV include dysfunctions of liver, skeletal
muscles and the nervous system. They often lead to early death or
strongly decrease the quality of life in adult patients. It is not clear
which of the possible mechanisms leads to the symptoms, whether it
is an effect of energy metabolism disruption or mechanical damage.
In our study we characterize the following parameters of human
skin ﬁbroblasts (from GSD IV patients and healthy controls):
respiration rate, mitochondrial morphology, respiratory complexes
content and GBE1 level.
We ﬁnd a difference in the expression levels of respiratory chain
complexes III and IV between cells with mutated GBE1 and controls.
Our further studies are aimed at ﬁnding whether those differences
are a result of the cell adaptation to glycogenmetabolismmalfunction
or are secondary to mechanical cell damage.
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There is accumulating evidence that mitochondrial pathway of
apoptosis can be regulated at post-cytochrome c level by the
mechanism involving reduction of cytosolic cytochrome c. We and
others have shown that oxidized cytochrome c is more potent in
caspase activation than reduced form and that chemicals and enzymes
that reduce cytochrome c may prevent caspase activation in several
models of mitochondria-mediated cell death. In this study, we present
our ﬁndings demonstrating that polyphenolic redox active plant
compounds anthocyanins may prevent ischaemia-induced caspase
activation in perfused rat heart and that this capacity of anthocyanins
correlates with their cytochrome c reducing activity. We also demon-
strate that the redox state of cytosolic cytochrome c may be regulated
by mitochondria. In apoptotic cells with leaky outer membrane,
cytosolic cytochrome cmay be oxidized by cytochrome oxidase. Besides
cytochrome c-oxidizing activity, mitochondria have NADH-dependent
external cytochrome c-reducing activity. We found that mitochondria
from different tissues have variable NADH-dependent external cyto-
chrome c-reducing activity: the highest activity was found in liver
mitochondria, the lowest — in brain mitochondria. External NADH-
cytochrome c reductase activity was found to be insensitive to nitric
oxide, but was inhibitable by S-nitrosothiols indicating involvement of
-SH groups in activity of the enzyme. This NADH-dependent cyto-
chrome c reducing activity is also suppressed in some pathological
states such as during heart ischaemia. The activity is partially inhibited
by DIDS, a selective inhibitor of anion channels. In liver mitochondria,
cytochrome b5 reductase is the main enzyme responsible for NADH-
dependent reduction of external cytochrome c. In contrast, heart
mitochondria have relatively low content of this enzyme, and when
VDAC (porin) was puriﬁed from heart mitochondria it was found to
possess NADH-dependent cytochrome c reducing activity. Altogether,
our data suggest that reduction of cytosolic cytochrome c by redox
active anthocyanins can prevent ischaemia-induced cell death in the
heart and that mitochondria can regulate apoptosis by changing the
redox state of cytochrome c released into cytosol.
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